Literature DB >> 10022892

The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription.

M Ohno1, M Zannini, O Levy, N Carrasco, R di Lauro.   

Abstract

The gene encoding the Na/I symporter (NIS) is expressed at high levels only in thyroid follicular cells, where its expression is regulated by the thyroid-stimulating hormone via the second messenger, cyclic AMP (cAMP). In this study, we demonstrate the presence of an enhancer that is located between nucleotides -2264 and -2495 in the 5'-flanking region of the NIS gene and that recapitulates the most relevant aspects of NIS regulation. When fused to either its own or a heterologous promoter, the NIS upstream enhancer, which we call NUE, stimulates transcription in a thyroid-specific and cAMP-dependent manner. The activity of NUE depends on the four most relevant sites, identified by mutational analysis. The thyroid-specific transcription factor Pax8 binds at two of these sites. Mutations that interfere with Pax8 binding also decrease transcriptional activity of the NUE. Furthermore, expression of Pax8 in nonthyroid cells results in transcriptional activation of NUE, strongly suggesting that the paired-domain protein Pax8 plays an important role in NUE activity. The NUE responds to cAMP in both protein kinase A-dependent and -independent manners, indicating that this enhancer could represent a novel type of cAMP responsive element. Such a cAMP response requires Pax8 but also depends on the integrity of a cAMP responsive element (CRE)-like sequence, thus suggesting a functional interaction between Pax8 and factors binding at the CRE-like site.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10022892      PMCID: PMC83998          DOI: 10.1128/MCB.19.3.2051

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

1.  Thyroid transcription factor-1 activates the promoter activity of rat thyroid Na+/I- symporter gene.

Authors:  T Endo; M Kaneshige; M Nakazato; M Ohmori; N Harii; T Onaya
Journal:  Mol Endocrinol       Date:  1997-10

2.  Membrane localization of cAMP-dependent protein kinase amplifies cAMP signaling to the nucleus in PC12 cells.

Authors:  S Cassano; A Gallo; V Buccigrossi; A Porcellini; R Cerillo; M E Gottesman; E V Avvedimento
Journal:  J Biol Chem       Date:  1996-11-22       Impact factor: 5.157

3.  TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation.

Authors:  M Zannini; V Avantaggiato; E Biffali; M I Arnone; K Sato; M Pischetola; B A Taylor; S J Phillips; A Simeone; R Di Lauro
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

4.  Characterization of the rat thyroid iodide transporter using anti-peptide antibodies. Relationship between its expression and activity.

Authors:  A Paire; F Bernier-Valentin; S Selmi-Ruby; B Rousset
Journal:  J Biol Chem       Date:  1997-07-18       Impact factor: 5.157

5.  Induction of nerve growth factor-induced gene-B (NGFI-B) as an early event in the cyclic adenosine monophosphate response of dog thyrocytes in primary culture.

Authors:  B Pichon; C Jimenez-Cervantes; I Pirson; C Maenhaut; D Christophe
Journal:  Endocrinology       Date:  1996-11       Impact factor: 4.736

6.  Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells.

Authors:  T Kogai; T Endo; T Saito; A Miyazaki; A Kawaguchi; T Onaya
Journal:  Endocrinology       Date:  1997-06       Impact factor: 4.736

7.  Characterization of the thyroid Na+/I- symporter with an anti-COOH terminus antibody.

Authors:  O Levy; G Dai; C Riedel; C S Ginter; E M Paul; A N Lebowitz; N Carrasco
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

8.  Cell type-specific protein-DNA interactions at the cAMP response elements of the prohormone convertase 1 promoter. Evidence for additional transactivators distinct from CREB/ATF family members.

Authors:  E Jansen; T A Ayoubi; S M Meulemans; W J Van de Ven
Journal:  J Biol Chem       Date:  1997-01-24       Impact factor: 5.157

9.  Redundant domains contribute to the transcriptional activity of the thyroid transcription factor 1.

Authors:  M De Felice; G Damante; M Zannini; H Francis-Lang; R Di Lauro
Journal:  J Biol Chem       Date:  1995-11-03       Impact factor: 5.157

10.  Cloning and characterization of the thyroid iodide transporter.

Authors:  G Dai; O Levy; N Carrasco
Journal:  Nature       Date:  1996-02-01       Impact factor: 49.962

View more
  65 in total

1.  Expression and function of the homeodomain-containing protein Hex in thyroid cells.

Authors:  L Pellizzari; A D'Elia; A Rustighi; G Manfioletti; G Tell; G Damante
Journal:  Nucleic Acids Res       Date:  2000-07-01       Impact factor: 16.971

Review 2.  Regulation of sodium/iodide symporter.

Authors:  S M Jhiang
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

3.  WBP-2, a WW domain binding protein, interacts with the thyroid-specific transcription factor Pax8.

Authors:  Roberto Nitsch; Tina Di Palma; Anna Mascia; Mariastella Zannini
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

4.  Pioglitazone induces a proadipogenic antitumor response in mice with PAX8-PPARgamma fusion protein thyroid carcinoma.

Authors:  Melissa E Dobson; Ericka Diallo-Krou; Vladimir Grachtchouk; Jingcheng Yu; Lesley A Colby; John E Wilkinson; Thomas J Giordano; Ronald J Koenig
Journal:  Endocrinology       Date:  2011-09-27       Impact factor: 4.736

5.  Adipogenic Differentiation of Thyroid Cancer Cells Through the Pax8-PPARγ Fusion Protein Is Regulated by Thyroid Transcription Factor 1 (TTF-1).

Authors:  Bin Xu; Michael O'Donnell; Jeffrey O'Donnell; Jingcheng Yu; Yanxiao Zhang; Maureen A Sartor; Ronald J Koenig
Journal:  J Biol Chem       Date:  2016-07-19       Impact factor: 5.157

6.  The thyroid cancer PAX8-PPARG fusion protein activates Wnt/TCF-responsive cells that have a transformed phenotype.

Authors:  Dang Vu-Phan; Vladimir Grachtchouk; Jingcheng Yu; Lesley A Colby; Max S Wicha; Ronald J Koenig
Journal:  Endocr Relat Cancer       Date:  2013-09-11       Impact factor: 5.678

7.  GLIS3 is indispensable for TSH/TSHR-dependent thyroid hormone biosynthesis and follicular cell proliferation.

Authors:  Hong Soon Kang; Dhirendra Kumar; Grace Liao; Kristin Lichti-Kaiser; Kevin Gerrish; Xiao-Hui Liao; Samuel Refetoff; Raja Jothi; Anton M Jetten
Journal:  J Clin Invest       Date:  2017-10-30       Impact factor: 14.808

8.  Identification of cyclic adenosine 3',5'-monophosphate response element modulator as an activator of the human sodium/iodide symporter upstream enhancer.

Authors:  Mike S Fenton; Kenneth M Marion; Jerome M Hershman
Journal:  Endocrinology       Date:  2008-01-17       Impact factor: 4.736

9.  Gbetagamma dimers released in response to thyrotropin activate phosphoinositide 3-kinase and regulate gene expression in thyroid cells.

Authors:  Miguel A Zaballos; Bibian Garcia; Pilar Santisteban
Journal:  Mol Endocrinol       Date:  2008-01-17

10.  A De novo PAX8 mutation in a Chinese child with congenital thyroid dysgenesis.

Authors:  Hui Zou; Jian Chai; Shiguo Liu; Hongwei Zang; Xiaoxia Yu; Liping Tian; Huichao Li; Bingjuan Han
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.